Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Under its new policy, Blue Cross Blue Shield of Massachusetts said Thursday it will continue to cover the meds, known as GLP-1s, in its standard health benefits when theyre prescribed for diabetes but not for obesity
Heres what you need to know: 1
Metformin is thought to have an anorexic effect partly by promoting the secretion of GLP-1 and activating afferent inputs from the intestinal tract to the NTS [24], but there is currently no evidence that the degree of weight loss exceeds 5%, which is the standard for use as an anti-obesity drug
The honest framing is this: if youre already on semaglutide and losing weight effectively, adding berberine is unlikely to meaningfully accelerate that weight loss
US$ 29.12
US$ 21.64
US$ 20.57
